A comprehensive view of Non-Vaccine Biologics. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Government & Public Policy Market Intelligence Service.
Recent Articles
sample of recent headlines, press releases and get more..
Efforts are ongoing to rescue gene therapy for rare disease ADA-SCiD; researchers at UCL and UCLA are developing the non-FDA approved simoladagene autotemcel therapy, supported by nonprofits
Published:
July 26, 2024
by MarketLine
|
Patent Issued for Methods for increasing lean body mass with an exercise regimen and a GDF8 inhibitor that is an anti-GDF8 antibody (USPTO 12029788)
Published:
July 26, 2024
by Disease Prevention Daily
|
Pfizer advances hemophilia A gene therapy and honors cancer pharmacogenomics research; company also reduces greenhouse gas emissions in Spain and engages Greek pharmacy students for educational visit
Published:
July 25, 2024
by Industry Intelligence Inc.
|
Pfizer announces positive Phase 3 results for hemophilia A gene therapy giroctocogene fitelparvovec; trial shows a significant reduction in mean total annualized bleeding rate
Published:
July 24, 2024
by Pfizer Inc.
|
Patent Issued for Anti-CTLA-4 antibodies and uses thereof (USPTO 12024570)
Published:
July 23, 2024
by Biotech Business Daily
|
Ask us about our Government & Public Policy market view
Trending Chart
Interactive chart with headline count